Showing results (221-230 of 267) with videos related to
Sort By:
Pageof 27
Health Care Transitions|June 1, 2026
Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related supportJayanne Forrest, Claudio Galea, Caren Steinway, et al.Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.American Journal of Hematology|November 29, 2011
Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke preventionJanet L Kwiatkowski, Alan R Cohen, Julian Garro, et al.British Journal of Clinical Pharmacology|April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trialAlexandra Power-Hays, Ruth Namazzi, Min Dong, et al.JAMA Network Open|July 13, 2026
Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell DiseaseApoorva S Iyengar, Tanisha Belton, Jack Chen, et al.Medicine|May 1, 2004
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and JapanJun-Ichi Nishimura, Yuzuru Kanakura, Russell E Ware, et al.British Journal of Haematology|July 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trialAngela Rankine-Mullings, Marvin Reid, Deanne Soares, et al.Journal of Pediatric Hematology/Oncology|January 25, 2003
Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell diseaseDeborah Dean, Lynne Neumayr, Dana M Kelly, et al.American Journal of Hematology|August 4, 2009
Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patientsSara C Koenig, Esmira Becirevic, Miriam S C Hellberg, et al.Pageof 27